ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Vallourec

Vallourec (VK)

16.42
0.105
(0.64%)
Closed January 01 11:30AM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
16.42
Bid
16.27
Ask
16.50
Volume
99,007
16.28 Day's Range 16.425
12.785 52 Week Range 18.20
Market Cap
Previous Close
16.315
Open
16.28
Last Trade
50
@
16.42
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
516,202
Shares Outstanding
229,877,070
Dividend Yield
-
PE Ratio
7.61
Earnings Per Share (EPS)
2.16
Revenue
5.11B
Net Profit
495.91M

About Vallourec

Sector
Steel Pipe And Tubes
Industry
Steel Pipe And Tubes
Headquarters
Meudon, Hauts-de-seine, Fra
Founded
1899
Vallourec is listed in the Steel Pipe And Tubes sector of the Euronext with ticker VK. The last closing price for Vallourec was 16.32 €. Over the last year, Vallourec shares have traded in a share price range of 12.785 € to 18.20 €.

Vallourec currently has 229,877,070 shares outstanding. The market capitalization of Vallourec is 3.75 € billion. Vallourec has a price to earnings ratio (PE ratio) of 7.61.

VK Latest News

Appointment of Annelise le Gall as Employee Representative to the Board of Directors

APPOINTMENT OF ANNELISE LE GALL AS EMPLOYEE REPRESENTATIVE TO THE BOARD OF DIRECTORS Meudon (France), December 11, 2024 – Vallourec, a global leader in premium seamless tubular solutions...

Vallourec to Sell Logistics Group (Indonesia) for €20 Million

VALLOUREC TO SELL LOGISTICS GROUP (INDONESIA) FOR €20 MILLION Meudon (France), November 25, 2024 – Vallourec, a world leader in premium seamless tubular solutions, announces today that it has...

Vallourec Third Quarter 2024 Results

Meudon (France), November 15th, 2024 Vallourec, a world leader in premium tubular solutions, announces today its results for the third quarter 2024. The Board of Directors of Vallourec SA...

Vallourec Announces the Creation of an Operations Department and Strengthens Its Process and Engineering Department

VALLOUREC ANNOUNCES THE CREATION OF AN OPERATIONS DEPARTMENT AND STRENGTHENS ITS PROCESS AND ENGINEERING DEPARTMENT Meudon (France), November 5, 2024 – Since its launch, New Vallourec plan has...

Invitation: Vallourec Q3 2024 Results Release - Conference Call on Friday, November 15, 2024

Q3 & 9M 2024 Results Release and Conference Call Friday, November 15th, 2024 Vallourec will publish Third Quarter and Nine Month 2024 Results on November 15th, 2024 at 07:30 AM CET. Philippe...

Vallourec to Showcase Its Cutting-Edge Energy Transition Solutions at ADIPEC 2024

VALLOUREC TO SHOWCASE ITS CUTTING-EDGE ENERGY TRANSITION SOLUTIONS AT ADIPEC 2024 Meudon (France), October 30, 2024 – Vallourec, a world leader in premium seamless tubular solutions, will take...

VALLOUREC AND ASMO SIGN A STRATEGIC PARTNERSHIP

VALLOUREC AND ASMO SIGN A STRATEGIC PARTNERSHIP Meudon (France), October 21, 2024 – Vallourec, a world leader in premium seamless tubular solutions, announces the signing of a Memorandum of...

Vallourec Secures Major Contract With Petrobras

VALLOUREC SECURES MAJOR CONTRACT WITH PETROBRAS Meudon (France), September 27, 2024 – Vallourec, a world leader in premium seamless tubular solutions, announces, after a competitive process, the...

Mattr Signs Definitive Agreement to Sell Its Brazilian Pipe Coating Business to Vallourec For US$17.5M

TORONTO, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Mattr Corp. (“Mattr” or the “Company”) (TSX: MATR) announced today that it has entered into a definitive agreement to sell its subsidiary, Thermotite...

Vallourec Enhances Its Line Pipe Coating Solutions With the Acquisition of Thermotite do Brasil

VALLOUREC ENHANCES ITS LINE PIPE COATING SOLUTIONS WITH THE ACQUISITION OF THERMOTITE DO BRASIL Meudon (France), September 16, 2024 – Vallourec, a world leader in premium seamless tubular...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.0950.58192955589616.32516.5116.22523131616.35233631DE
4-0.04-0.24301336573516.4617.3116.0650213816.65779892DE
122.3216.453900709214.117.3113.5551620215.80880988DE
261.1457.4959083469715.27517.3112.8150109014.87674442DE
522.2215.633802816914.218.212.78565922815.07729085DE
1567.84591.48688046658.57518.26.595102861811.91251261DE
26013.652493.2080924862.768490.6513777117.67344636DE

VK - Frequently Asked Questions (FAQ)

What is the current Vallourec share price?
The current share price of Vallourec is 16.42 €
How many Vallourec shares are in issue?
Vallourec has 229,877,070 shares in issue
What is the market cap of Vallourec?
The market capitalisation of Vallourec is EUR 3.75B
What is the 1 year trading range for Vallourec share price?
Vallourec has traded in the range of 12.785 € to 18.20 € during the past year
What is the PE ratio of Vallourec?
The price to earnings ratio of Vallourec is 7.61
What is the cash to sales ratio of Vallourec?
The cash to sales ratio of Vallourec is 0.74
What is the reporting currency for Vallourec?
Vallourec reports financial results in EUR
What is the latest annual turnover for Vallourec?
The latest annual turnover of Vallourec is EUR 5.11B
What is the latest annual profit for Vallourec?
The latest annual profit of Vallourec is EUR 495.91M
What is the registered address of Vallourec?
The registered address for Vallourec is 12 RUE DE LA VERRERIE, MEUDON, HAUTS-DE-SEINE, 92190
What is the Vallourec website address?
The website address for Vallourec is www.vallourec.com
Which industry sector does Vallourec operate in?
Vallourec operates in the STEEL PIPE AND TUBES sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BE0945331669ARKimedes Fonds NV
8.30 €
(43.10%)
125
ALSAFSAFE
0.072 €
(33.58%)
267.41k
IEXIEX Group NV
2.16 €
(27.06%)
12.41k
PROACProactis SA
0.066 €
(25.71%)
216
ALNN6Enensys
1.03 €
(23.80%)
118.24k
EIFDSTour Eiffel DS
0.006 €
(-50.00%)
257.23k
MLWEYWeya
0.013 €
(-29.73%)
150k
NICBSNicox SA
0.0131 €
(-25.99%)
10
ALALOAcheterLouerFR
0.2221 €
(-20.65%)
5.57k
SEQUASequana medical NV
3.06 €
(-13.07%)
623.09k
ATOAtos SE
0.0026 €
(4.00%)
555.36M
ALCYBCybergun
0.0001 €
(0.00%)
127.25M
BCPBanco Comercial Portugues SA
0.4647 €
(-0.06%)
17.83M
LATLatecoere
0.0101 €
(0.00%)
15.38M
EDPEDP SA
3.091 €
(-0.26%)
6.59M

Discussion

View Full Feed
juicyjuice10002 juicyjuice10002 3 minutes ago
That is the reason for settlement as per the negotiation between president Trump and the investors represented by Mr. Bill Ackman who read the book Art of Deal. Mr Brandon could never make a deal. There are wars all over the world thanks to Mr. Brandon.
FNMA
shotaduck shotaduck 5 minutes ago
Well I'm thinking henry did this big push to hold off the big sell-off at end of year. Nothing going on here...
PHIL
MasterBlastr MasterBlastr 7 minutes ago
Drew Lock will probably have a job, somewhere.
UOENO UOENO 8 minutes ago
Nice! Now let's see if anyone other than the five people on this board are interested.
MEDH
Tamboo Tamboo 11 minutes ago
HAPPY NEW YEAR to all GS stocks investors WISH we all make Huge Gain in 2025 
GVSI
Whale Gunna Whale Gunna 12 minutes ago
You're a low IQ basher, possibly mid IQ pumper 
BANT
GVInvestments GVInvestments 12 minutes ago
Its up to 2.6 million views now. Thats a potential 2.6 Million shareholders that could possibly buy Millions of shares.
FNMA
chino98 chino98 13 minutes ago
Happy new year guys 🥳 XRP is taking over 2025😎
XRPUSD
FNM500K FNM500K 17 minutes ago
Let's check in this time next year and see how things stand. Good luck all!! 
FNMA
spectrader82 spectrader82 19 minutes ago
We need CE off. How will that happen?
CCTL
Vexari Vexari 21 minutes ago
Question

If humans evolved from apes

Why

Are there still apes
Toronto_Trader Toronto_Trader 21 minutes ago
I guess Americans have it easier. Odd that it’s inconsistent.

Happy new year
GVSI
nowwhat2 nowwhat2 23 minutes ago
NOW what tho ????.......

https://investorshub.advfn.com/uimage/uploads/2025/1/1/dhgvabtc_121212_31_CAPT_9pm_HNY_YUP.jpg




HNY
BTCUSD
HyGro HyGro 26 minutes ago
Merck has made numerous oncology acquisition in 2023-2024 all while have clear visibility of DCVax-L's clinical data as well as the SPORE trial results (as they were part of the trial). Here's their deals, all passing over NWBO:
In 2023 and 2024, Merck has made several cancer acquisitions a
NWBO
dig4gold dig4gold 26 minutes ago
Happy New Year! 2025 is going to be epic.
CGAC
Green Leaf Smoker Green Leaf Smoker 26 minutes ago
Unfortunely just as in the past w/ news of progressive legalization it doesn't / won't translate to anything of value to this play 💩 MJNA 💩
MJNA
Green Leaf Smoker Green Leaf Smoker 28 minutes ago
Ding Ding Ding ....Bingo we have a winner!!!
PHIL
danieldeubank danieldeubank 31 minutes ago
Happy New Year to all including ColdDarkHole!
NB
dstock07734 dstock07734 33 minutes ago
I expect something of tsunami scale after the approval.
I don't think the booster stuff in 10Q is about poly-iclc or IL-7. If the party that provides the complementary technology is a BP, the one that provides the replacement for BCG is also a BP. It is my understanding that LP always likes t
BCG
Dodger1 Dodger1 35 minutes ago
It's True
AABB
Top Penny Top Penny 37 minutes ago
This will stay .0001 until March, mark it down.
PSRU
Dodger1 Dodger1 37 minutes ago
Happy New Year... $AABB
AABB

Your Recent History

Delayed Upgrade Clock